Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Cardiol Therapeutics (CRDL)

Cardiol Therapeutics (CRDL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,709
  • Shares Outstanding, K 64,043
  • Annual Sales, $ 60 K
  • Annual Income, $ -25,240 K
  • 60-Month Beta -0.74
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.00
Trade CRDL with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.29
  • Most Recent Earnings -0.10 on 11/10/22
  • Next Earnings Date 03/22/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 301.33% ( -321.38%)
  • Historical Volatility 89.27%
  • IV Percentile 71%
  • IV Rank 24.79%
  • IV High 1,140.37% on 09/23/22
  • IV Low 24.85% on 03/16/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 3
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 2,599
  • Open Int (30-Day) 2,590

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.09
  • Growth Rate Est. (year over year) +1,110,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5000 +40.68%
on 12/30/22
0.8098 -13.14%
on 01/13/23
+0.1784 (+33.98%)
since 12/27/22
3-Month
0.4734 +48.58%
on 12/06/22
0.8499 -17.24%
on 12/13/22
+0.1034 (+17.23%)
since 10/27/22
52-Week
0.4734 +48.58%
on 12/06/22
2.0800 -66.18%
on 04/14/22
-1.1766 (-62.59%)
since 01/27/22

Most Recent Stories

More News
Cardiol Therapeutics Announces First Patient Enrolled in Phase II Study Evaluating CardiolRx(TM) for the Treatment of Recurrent Pericarditis

The Cleveland Clinic Recruits First Participant in the Multi-center U.S. StudyOakville, Ontario--(Newsfile Corp. - January 17, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or...

CRDL.TO : 0.95 (+5.56%)
CRDL : 0.7034 (+3.06%)
Here's Why Cardiol Therapeutics Inc. (CRDL) Could be Great Choice for a Bottom Fisher

Cardiol Therapeutics Inc. (CRDL) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions...

CRDL : 0.7034 (+3.06%)
Hot Debate Over Myocarditis Risk Shines Spotlight on Heart Disease

Palm Beach, FL – July 26, 2022 – FinancialNewsMedia.com News Commentary – As COVID-19 vaccines for kids achieve the Centers for Disease Control and Prevention (CDC) recommendation, concern it could...

CRDL : 0.7034 (+3.06%)
CRDL.TO : 0.95 (+5.56%)
JNJ : 168.23 (-0.39%)
TAK : 16.03 (-0.43%)
NVO : 138.09 (+0.40%)
BMY : 72.45 (-0.74%)
Hot Debate Over Myocarditis Risk Shines Spotlight on Heart Disease

/PRNewswire/ -- As COVID-19 vaccines for kids achieve the Centers for Disease Control and Prevention (CDC) recommendation, the concern that it could increase...

CRDL.TO : 0.95 (+5.56%)
JNJ : 168.23 (-0.39%)
TAK : 16.03 (-0.43%)
NVO : 138.09 (+0.40%)
BMY : 72.45 (-0.74%)
CRDL : 0.7034 (+3.06%)
Air Pollution is a Global Heart and Lung Health Concern

/PRNewswire/ -- Particulate matter or particle pollution is a significant contributor to heart and lung disease. Individuals most affected by poor air quality...

CRDL.TO : 0.95 (+5.56%)
GSK : 35.30 (-0.11%)
AZN : 65.53 (-0.70%)
REGN : 742.83 (+0.07%)
CRDL : 0.7034 (+3.06%)
Air Pollution is a Global Heart and Lung Health Concern

Palm Beach, FL – July 18, 2022 – FinancialNewsMedia.com News Commentary – Particulate matter or particle pollution is a significant contributor to heart and lung disease. Individuals most affected...

CRDL : 0.7034 (+3.06%)
CRDL.TO : 0.95 (+5.56%)
GSK : 35.30 (-0.11%)
AZN : 65.53 (-0.70%)
REGN : 742.83 (+0.07%)
The Healthcare Companies Fighting the World’s Biggest Killers

Palm Beach, FL – July 13, 2022 – FinancialNewsMedia.com News Commentary – Some of the most prevalent health conditions on the planet claim millions of lives every year. Companies from across the...

CRDL : 0.7034 (+3.06%)
CRDL.TO : 0.95 (+5.56%)
VRNA : 22.43 (-1.36%)
PODD : 285.50 (-0.22%)
NVS : 89.49 (-0.39%)
The Healthcare Companies Fighting the World's Biggest Killers

/PRNewswire/ -- Some of the most prevalent health conditions on the planet claim millions of lives every year. Companies from across the healthcare sector are...

CRDL.TO : 0.95 (+5.56%)
VRNA : 22.43 (-1.36%)
PODD : 285.50 (-0.22%)
NVS : 89.49 (-0.39%)
CRDL : 0.7034 (+3.06%)
Tackling Recurring Health Conditions Offers Hope to Patients

Palm Beach, FL – June 21, 2022 – FinancialNewsMedia.com News Commentary – Being diagnosed with a health condition can often come as a shock but finding out it can recur is a double blow, particularly...

TECK : 41.34 (-0.74%)
CRDL : 0.7034 (+3.06%)
CRDL.TO : 0.95 (+5.56%)
MRK : 105.38 (-1.39%)
TECH : 81.19 (+1.08%)
NTRA : 43.74 (+2.29%)
As Health Problems Mount Patients Welcome New Treatments

Palm Beach, FL – June 14, 2022 – FinancialNewsMedia.com News Commentary – There are several serious health problems facing society today. Some, like heart disease, gastrointestinal diseases, cancer,...

CRDL : 0.7034 (+3.06%)
CRDL.TO : 0.95 (+5.56%)
TAK : 16.03 (-0.43%)
ABT : 109.95 (-1.01%)
BMY : 72.45 (-0.74%)
NVO : 138.09 (+0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cardiol Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease. The company's lead product consist CardiolRx(TM). Cardiol Therapeutics Inc. is based in Oakville, ON.

See More

Key Turning Points

3rd Resistance Point 0.7870
2nd Resistance Point 0.7611
1st Resistance Point 0.7218
Last Price 0.7034
1st Support Level 0.6566
2nd Support Level 0.6307
3rd Support Level 0.5914

See More

52-Week High 2.0800
Fibonacci 61.8% 1.4663
Fibonacci 50% 1.2767
Fibonacci 38.2% 1.0871
Last Price 0.7034
52-Week Low 0.4734

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar